top of page
![]() | ![]() |
---|
Smartdrug helps private and institutional investors assessing the potential of biotech/life science companies before committing for an investment round and during the entire investment life cycle.
We go beyond simple "due diligence".
We go beyond the Surface
We understand in depth and communicate clearly without bias
We evaluate both the technical gaps (status of the scientific package and alignment with the selling proposition, possible manufacturing problems, correlation between the intrinsic carachteristics of the product, the safety and the indication), as well as soft elements (founders' approach, their leadership potential and commitment, the match between their role and their skills, the aptness of the cap-table, the existing management composition and competence, the governance structure and eventual conflict of interests).
​
We are aware that there is no such a thing as a "defined development plan", but the accuracy of every plan depends on the ability to syncronize the impact of frame-factors (such as the specific technology and indication), with the capacity to sistematically take the suitable decision and action during the implementation phase, with a far-reaching vision.
​
The difference between a good strategy and a succesful strategy relies in removing the obstacles to its implementation and consitently take the necessary action
​
We can assess the probability of various scenarios, bullet-proof the available business plan, define realistic timelines till next inflection point weighting the impact of different possible events, but above all we propose a suitable action plan and we make sure it is implementable.
​
We avoid utopic forecasts leading to imaginative, unfitting financing rounds.
​
If required, we join our forces with the existing start-up teams to follow throught and implement solutions/changes and ensure the best choices and decisions are taken during the entire investment life cycle, by closely advising and collaborating both strategically and operationally with all stakeholders.
​
How do we do that?
We have seen it all, we understand in depth, we see beyond the horizon, we proud ourselves of high integrity and we are immune to conflicts of interest.
We tell you the bare Truth
​
Listen to us
bottom of page